| Name | Title | Contact Details |
|---|
Drager is an international leader in the fields of medical and safety technology. The family-owned company was founded in Lubeck, Germany, in 1889. The company`s long-term success is based on the four key strengths of its value-driven culture: customer intimacy, professional employees, continuous innovation and a commitment to outstanding quality. Drager offers its customers anaesthesia workstations, medical ventilation, patient monitoring as well as neonatal care for premature babies and newborns. With ceiling supply units, IT solutions for the OR, and gas management systems the company is at the customer`s side throughout the entire hospital. Emergency response services, law and regulatory enforcement and the industry trust in Drager`s integrated hazard management, in particular for personal protection and plant safety. This includes: respiratory protection equipment, stationary and portable gas detection systems, professional diving equipment and systems, as well as alcohol and drug impairment detection. In collaboration with its customers Dräger develops customized solutions, such as entire fire training systems, training concepts and workshops. Drager has more than 13.700 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
Twine Health is new kind of healthcare technology company that takes a person-centric approach to collaborative care. Most patient-centric paradigms are infected by the age-old assumption that patients are their conditions, and carry the hubris that patients can be "fixed" by throwing resources at them. To us, patients are people, not numbers. We strive to give them tools to easily understand and manage their unique health situation, and enhance relationships with their care teams.
Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.
A. Daigger and Company has been a leader in the scientific products industry since 1894.
A B Dental Trends is a Lynden, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.